Munsie Jeffrey A

CIK 00017030412 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001703041

Recent Transactions

20 trades

Disposition to Issuer
CONCERT PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2023-03-06−42,430→ 0 total
Disposition to Issuer
CONCERT PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2023-03-06−100,000→ 0 total
Disposition from Tender
CONCERT PHARMACEUTICALS, INC.
Common Stock
2023-03-06−38,350→ 0 total
Disposition to Issuer
CONCERT PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2023-03-06−51,850→ 0 total
Disposition to Issuer
CONCERT PHARMACEUTICALS, INC.
Common Stock
2023-03-06−49,699→ 0 total
Sale
CONCERT PHARMACEUTICALS, INC.
Common Stock
2023-02-15$8.34/sh−3,762→ 88,049 total
Sale
CONCERT PHARMACEUTICALS, INC.
Common Stock
2023-01-30$8.35/sh−8,493→ 91,811 total
Sale
CONCERT PHARMACEUTICALS, INC.
Common Stock
2023-01-06$7.25/sh−2,893→ 100,304 total
Sale
CONCERT PHARMACEUTICALS, INC.
Common Stock
2022-02-14$3.09/sh−3,762→ 103,197 total
Award
CONCERT PHARMACEUTICALS, INC.
Common Stock
2022-01-28+63,700→ 106,959 total
Sale
CONCERT PHARMACEUTICALS, INC.
Common Stock
2022-01-05$3.20/sh−2,894→ 43,259 total
Sale
CONCERT PHARMACEUTICALS, INC.
Common Stock
2021-02-16$7.32/sh−3,763→ 46,153 total
Award
CONCERT PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2021-01-05+51,850→ 51,850 total
Award
CONCERT PHARMACEUTICALS, INC.
Common Stock
2021-01-05+21,700→ 49,916 total
Award
CONCERT PHARMACEUTICALS, INC.
Common Stock
2020-02-14+28,216→ 28,216 total
Award
CONCERT PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2020-02-14+42,430→ 42,430 total
Award
CONCERT PHARMACEUTICALS, INC.
Employee Stock Option (Right to Buy)
2019-09-26+100,000→ 100,000 total
Award
MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
2018-12-11+45,000→ 45,000 total
Award
MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
2018-02-15+45,000→ 45,000 total
Award
MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
2017-06-06+550,000→ 550,000 total

Companies

Recent Filings

Address

C/O MERRIMACK PHARMACEUTICALS, INC. ONE KENDALL SQUARE, SUITE B7201

CAMBRIDGE, MA, 02139

View on SEC.gov